Obesity [3] (multiple letters)

New England Journal of Medicine

Volumn 338, Issue 1, 1998, Pages 64-65

  Seaton, T B ^a   Mendel, C M ^a   Weinstein, S P ^a   Eisenbud, E ^a   Hirsch, J ^a   Leibel, R L ^a   Rosenbaum, M ^a  

^a Knoll Pharmaceutical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN RECEPTOR; SIBUTRAMINE; VENLAFAXINE; CYCLOBUTANE DERIVATIVE; NEUROTRANSMITTER UPTAKE INHIBITOR;

HUMAN; LETTER; NEUROTOXICITY; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; TREATMENT PLANNING; WEIGHT REDUCTION; NOTE;

CYCLOBUTANES; HUMANS; NEUROTRANSMITTER UPTAKE INHIBITORS; OBESITY;

EID: 0031611335     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199801013380114     Document Type: Letter

References (0)